Anticoagulation Management http://www.acc.org/Feed?clinicalTopicID=677b3288-77e4-47f8-8697-3e2ce6a4dd87 Clinical Topic Feed: Anticoagulation Management en Eagle’s Eye View: Can Sugar-Sweetened Beverages and Fruit Juice Lead to Hypertension? /Latest-in-Cardiology/Articles/2026/07/08/14/16/eagles-eye-view-08jul2026 In this week’s View, Dr. Eagle looks at withdrawing guideline-directed medical therapy (GDMT) for patients with atrial fibrillation (AF). 1783520220000 Articles and Stories Discontinuation of Anticoagulation Following Catheter Ablation of AF: Updates With OCEAN Trial /Latest-in-Cardiology/Articles/2026/06/29/15/28/Discontinuation-of-Anticoagulation Current guidelines for management of atrial fibrillation (AF) recommend continuation of oral anticoagulation (OAC) following successful catheter ablation of AF for patients deemed at elevated thromboembolic risk. 1782921180000 Articles and Stories Poll Results: Brainstorm: Restarting Anticoagulation After Brain Bleed /Latest-in-Cardiology/Articles/2026/06/29/15/28/Poll-Results-Brainstorm This poll included a clinical vignette of an 80-year-old man with atrial fibrillation (AF), high thromboembolic risk, and multiple cardiovascular (CV) comorbidities who presented 2 months after a spontaneous lobar intracerebral hemorrhage while receiving reduced-dose apixaban... 1782913920000 Articles and Stories Peripheral Matters | Catheter-Based Intervention in Intermediate-Risk PE /Latest-in-Cardiology/Articles/2026/07/01/01/Peripheral-Matters Until the ACC/AHA guideline on the management of acute pulmonary embolism (PE) was published in February, more than a decade had passed since the last one. During this interval, catheter-based interventions have expanded substantially, reshaping management of intermediate-risk PE. 1782908220000 Articles and Stories ACC Featured Jobs For July 2026 /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1782902880000 Articles and Stories ACC Scientific Statement Addresses DOACs in Primary and Secondary Prevention of Thrombotic Events /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/ACC-Scientific-Statement-Addresses-DOACs Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk. 1782828120000 Articles and Stories ACC Scientific Statement Guides Use of Antiplatelet Therapy in Managing ASCVD /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/ACC-Scientific-Statement-Guides-Use-of-Antiplatelet-Therapy A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the risk of bleeding in this patient population. 1782828000000 Articles and Stories Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement https://www.jacc.org/doi/10.1016/j.jacc.2026.05.037 1782828000000 Guidelines Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement https://www.jacc.org/doi/10.1016/j.jacc.2026.05.033 1782828000000 Guidelines Discontinuation of Oral Anticoagulation After AF Catheter Ablation (ALONE-AF): ALONE, but Not the Only One /Latest-in-Cardiology/Articles/2026/06/29/15/28/Discontinuation-of-Oral-Anticoagulation The ALONE-AF (Anticoagulation One Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation) trial examined whether discontinuing oral anticoagulation (OAC) in patients with elevated stroke risk after catheter ablation of atrial fibrillation (AFCA) who remain free of atrial arrhythmias in the year after their indexed ablation leads to fewer adverse clinical outcomes. 1782752820000 Articles and Stories